Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

July 22, 2024

Study Completion Date

December 20, 2024

Conditions
Diabetes
Interventions
BEHAVIORAL

Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia)

The Hypoglycemia Champion (HC) pharmacist reviewed patient charts before conducting proactive outreach. They did not contact subjects with active psychiatric issues or those admitted to a skilled nursing facility. The patient's care team (PCP and APM) were also contacted for peer consent. The outreach process involved an initial phone call with a secure electronic message or mailed letter (for those without secure KPNC patient portal access) if the initial call was unsuccessful. A second and third phone call attempt was made for non-responders.

BEHAVIORAL

Usual care, after system-side dissemination of HOAP

Patients had their diabetes treated as usual by their diabetes care provider or primary care physician, after system-wide dissemination of HOAP.

Trial Locations (1)

94588

Kaiser Permanente Department of Research, Pleasanton

All Listed Sponsors
lead

Kaiser Permanente

OTHER